Standard Biotools Inc (LAB) - News Archive

In a move signaling its commitment to robust fiscal management and operational insight, Standard BioTools Inc. has appointed Alex Kim as Chief Financial Officer, effective November 11, 2024. This strategic decision come...

Standard BioTools Provides Financial Snapshot for Q3 2024On October 30, 2024, Standard BioTools Inc. (NASDAQ: LAB), a player in the Laboratory Analytical Instruments sector, released its unaudited interim financial resu...

Comprehensive Proteomics Profiling Unveils Novel Biomarkers and Insights into Nonalcoholic Steatohepatitis (NASH)Interest in nonalcoholic steatohepatitis (NASH) has burgeoned in recent years as researchers deepen their...

Standard BioTools Purchases Carterra LSA-XT System to Enhance SomaScan PlatformStandard BioTools Inc., a biotechnology company, has recently acquired the LSA-XT system from Carterra, a leading provider of screening and...

Standard BioTools Announces Operational Restructuring Plan to Drive Long-Term Profitable GrowthSOUTH SAN FRANCISCO, Calif., April 25, 2024 - Standard BioTools Inc. (Standard BioTools or the Company) (Nasdaq: LAB) today...

Standard BioTools Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the Boundaries of Tissue ImagingAdvancements in spatial biology have always been a crucial aspect of medical re...

In a groundbreaking announcement, Standard BioTools Inc. has revealed its strategic engagement with global biopharmaceutical company Bristol Myers Squibb, an alliance set to reshape the landscape of translational medici...

Standard BioTools Announces Exchange of Series B Convertible Preferred Stock for Common StockSOUTH SAN FRANCISCO, Calif., March 18, 2024 - Standard BioTools Inc. (Nasdaq: LAB) made an announcement today regarding the ex...

Next Gen Diagnostics and Standard BioTools Partner to Revolutionize Pathogen Sequencing AutomationSOUTH SAN FRANCISCO, Calif., Feb. 26, 2024 - Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose - Unleashing t...

Standard BioTools and Navignostics recently announced a significant collaboration to propel imaging capabilities in the realm of personalized medicine. The agreement aims to enhance the accessibility of Imaging Mass Cyt...

Glass Lewis Recommends Standard BioTools Stockholders Vote FOR Proposed Merger with SomaLogicSOUTH SAN FRANCISCO, Calif., Dec. 29, 2023 - Leading biotechnology company, Standard BioTools Inc. (Nasdaq: LAB), known for it...